PURPOSE: Pulmonary valve replacement long after repair of tetralogy of Fallot can improve cardiac function, functional status, and arrhythmia propensity. This has not been reported in Japan. We aim to evaluate the effects of pulmonary valve replacement in repaired tetralogy of Fallot. METHODS: Nineteen patients underwent pulmonary valve replacement after repair of tetralogy of Fallot, excluding Rastelli type operation, between August 1981 and August 2011. The results of the pulmonary valve replacement were assessed by analyzing preoperative and postoperative cardiothoracic ratio, cardiac function, functional status, QRS duration and durability of the prosthetic valves. RESULTS: There were neither operative nor late deaths. The Cardiothoracic ratio significantly improved from 61.0 ± 5.2 % preoperatively to 56.2 ± 4.8 % postoperatively (P < 0.001). The New York Heart association functional class significantly improved from 2.4 ± 0.8 preoperatively to 1.2 ± 0.4 postoperatively as well. Left ventricular ejection fraction showed significant improvement. QRS duration showed significant reduction. The freedom redo pulmonary valve replacement at 20 years was 100 %. CONCLUSION: Pulmonary valve replacement long after repair of previous tetralogy of Fallot had clinical benefits with low mortality. We recommend bioprosthesis for pulmonary valve replacement when adult-sized valve can be accommodated.
PURPOSE: Pulmonary valve replacement long after repair of tetralogy of Fallot can improve cardiac function, functional status, and arrhythmia propensity. This has not been reported in Japan. We aim to evaluate the effects of pulmonary valve replacement in repaired tetralogy of Fallot. METHODS: Nineteen patients underwent pulmonary valve replacement after repair of tetralogy of Fallot, excluding Rastelli type operation, between August 1981 and August 2011. The results of the pulmonary valve replacement were assessed by analyzing preoperative and postoperative cardiothoracic ratio, cardiac function, functional status, QRS duration and durability of the prosthetic valves. RESULTS: There were neither operative nor late deaths. The Cardiothoracic ratio significantly improved from 61.0 ± 5.2 % preoperatively to 56.2 ± 4.8 % postoperatively (P < 0.001). The New York Heart association functional class significantly improved from 2.4 ± 0.8 preoperatively to 1.2 ± 0.4 postoperatively as well. Left ventricular ejection fraction showed significant improvement. QRS duration showed significant reduction. The freedom redo pulmonary valve replacement at 20 years was 100 %. CONCLUSION: Pulmonary valve replacement long after repair of previous tetralogy of Fallot had clinical benefits with low mortality. We recommend bioprosthesis for pulmonary valve replacement when adult-sized valve can be accommodated.
Authors: R Scott McClure; Narendren Narayanasamy; Esther Wiegerinck; Stuart Lipsitz; Ann Maloney; John G Byrne; Sary F Aranki; Gregory S Couper; Lawrence H Cohn Journal: Ann Thorac Surg Date: 2010-05 Impact factor: 4.330
Authors: Roderick W C Scherptong; Mark G Hazekamp; Barbara J M Mulder; Olivier Wijers; Cees A Swenne; Ernst E van der Wall; Martin J Schalij; Hubert W Vliegen Journal: J Am Coll Cardiol Date: 2010-10-26 Impact factor: 24.094
Authors: Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel Journal: J Am Coll Cardiol Date: 2006-08-01 Impact factor: 24.094
Authors: Cheul Lee; Chun Soo Park; Chang-Ha Lee; Jae Gun Kwak; Soo-Jin Kim; Woo-Sup Shim; Jin Young Song; Eun Young Choi; Sang Yun Lee Journal: J Thorac Cardiovasc Surg Date: 2011-02-01 Impact factor: 5.209
Authors: Daniel Tobler; Andrew M Crean; Andrew N Redington; Glen S Van Arsdell; Christopher A Caldarone; Kumar Nanthakumar; Dominik Stambach; Laura Dos; Bernd J Wintersperger; Erwin N Oechslin; Candice K Silversides; Rachel M Wald Journal: Int J Cardiol Date: 2011-05-12 Impact factor: 4.164
Authors: J Therrien; S C Siu; L Harris; A Dore; K Niwa; J Janousek; W G Williams; G Webb; M A Gatzoulis Journal: Circulation Date: 2001-05-22 Impact factor: 29.690
Authors: Jamie L R Romeo; Johanna J M Takkenberg; Judith A A E Cuypers; Natasha M S de Groot; Pieter van de Woestijne; Nico Bruining; Ad J J C Bogers; M Mostafa Mokhles Journal: Eur J Cardiothorac Surg Date: 2020-09-01 Impact factor: 4.191